EINSTEIN NOODLES, LLC – Trademark Portfolio

Entity Type: 16

EINSTEIN NOODLES, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PRO GONE. The owner is based in CHARLESTON, SC.

126 SEVEN FARMS DRIVE

STE. 110

CHARLESTON, SC 29492

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

EINSTEIN NOODLES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (3 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does EINSTEIN NOODLES, LLC have?

EINSTEIN NOODLES, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 6 cancelled.

What trademark classes does EINSTEIN NOODLES, LLC file in?

EINSTEIN NOODLES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are EINSTEIN NOODLES, LLC's most well-known trademarks?

EINSTEIN NOODLES, LLC's registered trademark portfolio includes well-known marks such as PRO GONE. These are among 1 currently registered trademark in the portfolio.

What is EINSTEIN NOODLES, LLC's trademark registration success rate?

EINSTEIN NOODLES, LLC has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.